Trial Design and Rationale for Apollo, a Phase 3, Placebo-Controlled Study of Patisiran in Patients with Hereditary Attr Amyloidosis with Polyneuropathy
AuthID
P-00N-0SC
P-00N-0SC
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service